Proteins and Peptides

19 Apr 2007 Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD. Phase III clinical trial may commence shortly
19 Apr 2007 Viragen Announces European Multiferon(R) Licensing Agreement
18 Apr 2007 Dyax Initiates Confirmatory Phase 3 (EDEMA4) Trial for DX-88 for the Treatment of Hereditary Angioedema
18 Apr 2007 DeveloGen and Andromeda, a newly formed wholly-owned subsidiary of Clal Biotechnology Industries, Sign Term Sheet for Asset Purchase Agreement for the DiaPep277(R) Program
18 Apr 2007 Adnexus Therapeutics Announces Presentation at the American Association for Cancer Research (AACR) on Clinical Product Candidate, CT-322
18 Apr 2007 Prevascar Phase II Results
18 Apr 2007 OncoGenex Technologies Announces Phase II Data of OGX-011 in Metastatic
17 Apr 2007 Preclinical Data Show Alfacell's ONCONASE(R) Inhibits Tumor Growth of Non-Small Cell Lung Cancer, Breast Cancer Cells Poster Presented at AACR Annual Meeting
17 Apr 2007 Aranesp(R) Phase 3 Study in Patients with Active Cancer Not Receiving Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual Meeting
15 Apr 2007 Human Genome Sciences Reports Positive Interim Results of Phase 2b Trial of Albuferon(R)
13 Apr 2007 Affymax(R) Announces Results From Phase 2 Clinical Trial of Hematide(TM) for the Treatment of Anemia in Dialysis Patients
13 Apr 2007 Intarcia Therapeutics Announces Final Results From A Phase 2 Study Of Injectable Omega Interferon plus Ribavirin for the Treatment of Hepatitis C Genotype-1
13 Apr 2007 DX-88 for Hereditary Angioedema Meets Primary and Secondary Endpoints in Phase 3 Trial (EDEMA3(R))
12 Apr 2007 Follistim(R) introduced in Japan in a further indication for the treatment of infertility
12 Apr 2007 Nuvelo Announces Publication of NU206 Study Results in Gastroenterology
11 Apr 2007 Stem Cell Therapeutics Corp. Announces Positive Interim Results From its Currently Enrolling Phase IIa Clinical Program for NTx(TM)-265 in Acute Stroke
06 Apr 2007 PEGINTRON(TM) Approved in China for Treating Chronic Hepatitis B
05 Apr 2007 Eurand Announces Positive Phase III Clinical Study Results
04 Apr 2007 Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect with Lead RNAi Candidate
04 Apr 2007 New Data Confirm That Use of Levemir Can Limit Weight Gain
04 Apr 2007 Targanta Reports Improved Ability of Oritavancin to Stop Bacteria Growth In Vitro Compared With Other Glycopeptide Antibiotics
03 Apr 2007 Nautilus Biotech begins Phase I clinical trial in the USA for subcutaneous Belerofon(R) its long-lasting, Interferon-alpha drug.
03 Apr 2007 Helix BioPharma Corp. announces positive phase II clinical results with its Topical Interferon Alpha-2b
03 Apr 2007 Roche acquires THP to expand its therapeutic antibody research
03 Apr 2007 Diosynth Biotechnology Announces Agreement with Talecris Biotherapeutics for Process Development and Clinical Production of Recombinant Plasminogen

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top